Tech Company Financing Transactions
Geron Funding Round
On 11/7/2024, Geron landed $375 million in funding from Pharmakon Advisors.
Transaction Overview
Company Name
Announced On
11/7/2024
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$375,000,000
Round
Undisclosed
Investors
Pharmakon Advisors (Pedro Gonzalez)
Proceeds Purpose
The proceeds are expected to enable us to support the commercial launch of RYTELO in the U.S. and potential launch in the EU, complete our Phase 3 IMpactMF trial in relapsed/refractory myelofibrosis, invest in supply chain redundancy for RYTELO, and our general working capital requirements.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
919 E. Hillsdale Blvd 250
Foster City, CA 94404
USA
Foster City, CA 94404
USA
Phone
Website
Email Address
Overview
Powered by pioneering science, grounded in world-class expertise, and driven by purpose, Geron aims to change lives by changing the course of blood cancer. Nobel Prize-winning discoveries about an enzyme called telomerase and its impact on the uncontrolled proliferation of malignant cells were our beginning. The belief in the potential of a novel therapeutic approach targeting and inhibiting telomerase started our journey.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Scarlett
Chief Financial Officer
Michelle Robertson
Chief Medical Officer
Faye Feller
Chief Operating Officer
Andrew Grethlein
VP - Bus. Development
Edward Koval
VP - Bus. Development
Jim Ziegler
VP - General Counsel
Scott Samuels
VP - Human Resources
Shannon Odam
VP - Operations
Melissa Behrs
Browse more venture capital transactions:
Prev: 11/7/2024: PuppyGraph venture capital transaction
Next: 11/8/2024: Lerian venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document funding rounds that are announced publicly. VC transactions reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs